Rosett Max
- SEC CIK
- 0001994071
In the past year, 2 open-market sale filings worth $2.52M and no purchases.
Current role at each company
- IMNM Immunome Inc.Chief Financial Officeras of Jul 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.52M
- 2 filings
- Net
- −$2.52M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rosett Max as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Rosett MaxChief Financial Officer | SSale | −60.0K | $18.23 | −$1.09M | −52.6%54.0K after | 10b5-1 |
| Apr 3, 2026 (view filing) | Apr 2 | 1 day | Rosett MaxChief Financial Officer | SSale | −65.0K | $21.92 | −$1.42M | −54.6%54.0K after | 2 lots10b5-1 |
| Sep 20, 2024 (view filing) | Sep 19 | 1 day | Rosett MaxChief Financial Officer | SSale | −14.4K | $16.01 | −$230.2K | −23.2%47.5K after |